Please login to the form below
Novo Nordisk settles US insulin pricing dispute for $100m
Novo Nordisk admits no liability or wrongdoing but will pay investors $100m to “avoid the burden, inherent risk and expense of further litigation”
Mysterious big pharma company eyes US biotech Acceleron
Speculation is running high that a major pharma company will make a move on Massachusetts-based pulmonary and haematology biotech Acceleron this week
Lynparza significantly delays disease progression as first-line treatment in prostate cancer
New data show AstraZeneca and Merck‘s PARP inhibitor, Lynparza, delayed disease progression as a first-line treatment in advanced prostate cancer
Rocky start for Biogen’s Alzheimer’s drug Aduhelm
Controversial Alzheimer’s treatment Aduhelm is struggling to realise its potential, with only 100 patients receiving the therapy so far in the US
COVID-19 Pfizer/BioNTech booster approved by FDA and CDC
The plan to offer Americans a third, booster shot of the Pfizer/BioNTech COVID-19 vaccine has finally been waved through by the FDA and CDC
AstraZeneca invests in RNA tech platform
AstraZeneca will support research using VaxEquity’s RNA platform then pay at least $195m for each candidate that enters its pipeline
Gilead’s Veklury (remdesivir) cuts risk of severe COVID-19 by 87%
New data showing Gilead’s Veklury cuts the risk of hospitalisation for COVID-19 contradicts results of the World Health Organization’s Solidarity study
Amgen’s Biosimilar Trends Report shows benefit of competition from biosimilars
Competition created by biosimilars has delivered $9.8bn in savings over five years and could reduce patients’ out-of-pocket costs by $238m
FDA approves Seagen/Genmab’s antibody-drug conjugate Tivdak for women with advanced cervical cancer
The drug has been granted accelerated approval, and the companies have also released positive data on first-line treatment
Behaviour change theory
Behaviour change through teamwork – collaborating with stakeholders from across the health ecosystem. Chris Ross examines pharma’s adoption of behaviour change theories and finds an industry in need of a
-
Q&A: Claire GillisPME interviews VMLY&Rx's CEO
-
Q&A: Sarah GordonPME interviews Virgo Health's head of health
-
AstraZeneca chooses Ireland for $360m manufacturing siteThe next-generation facility will make small molecule active ingredients, future-proofing the company’s supply chain and boosting the Irish life sciences sector
-
New data for Tecentriq in early-stage lung cancerRoche’s PD-L1 blocker reduced the risk of disease recurrence and death for patients with stage 2-3a non-small cell lung cancer following surgery
-
Strong five-year survival data for Kisqali in breast cancerNovartis’ Kisqali plus letrozole offers more than a year survival benefit for postmenopausal women with HR+/HER2 advanced breast cancer
-
AstraZeneca’s Imfinzi provides sustained survival benefit for lung cancer patients
The drug tripled patient survival after three years in the longest-ever follow-up in extensive-stage small cell lung cancer
-
Biogen’s Vumerity recommended by CHMP in MSA thumbs up for Vumerity in the EU could ease the way for Biogen’s follow-up to Tecfidera in multiple sclerosis
-
New data from Moderna supports COVID boostersWaning immunity from its mRNA jab “support benefit” of a booster shot, says Moderna, while international scientists publish plea for evidence over politics
-
$47.5m research centre to seek genetic insights into diseaseThe Novo Nordisk Foundation and Broad Institute have teamed up to mine genetic data for disease insights and help develop the next generation of researchers
Latest appointments
-
David Hunt launches independent agency The ConsideredThe team includes Professor Shafi Ahmed, Aurora Archer, Jane Kidd and CCO Pete Armstrong
-
Amanda Pritchard becomes NHS England’s first female chief executivePritchard takes on the chief executive role after serving as the NHS’ chief operating officer for two years
-
Langland promotes Jake Davis to managing partnerDavis joined Langland in 2020 as business unit director of the agency’s PR and policy division
-
Ogilvy Health appoints Rebecca Carter to newly created head of social media roleThree new hires have also joined the dedicated healthcare communications team
-
Ashfield Health announces three new senior hiresAgustin Ramirez, Beverly Pisarczyk and Kory Koske take on various roles across the business
COVID-19 Updates and Daily News
Featured jobs
- Account Director, Medical & Brand Communications, London/ SE...
-
Highly competitive salary
- Editorial Director - UK, , EUROPE, REMOTE.
-
Highly Competitive Salary, Bonus &Benefits
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Management Trainer, Medical Communications, Londo...
-
Highly competitive salary
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- Medical Writer, Women’s health, Medical Communications agency, h...
-
Highly competitive salary
- Freelance Scientific Director, Medical Communications, London/ S...
-
Highly competitive salary
- Senior Account Director, Medical & Brand Communications, Lon...
-
Highly competitive salary
- FDA approves Seagen/Genmab’s antibody-drug conjugate Tivdak for women with advanced cervical cancer
- Gilead’s Veklury (remdesivir) cuts risk of severe COVID-19 by 87%
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- AstraZeneca’s Imfinzi provides sustained survival benefit for lung cancer patients
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- EU “still interested” in Valneva COVID vaccine despite UK snub
- Novo Nordisk settles US insulin pricing dispute for $100m
- Mysterious big pharma company eyes US biotech Acceleron
- COVID-19 changed change and communications will never be the same
- Understanding behaviour change: A Porterhouse Insights specialism
- Lynparza significantly delays disease progression as first-line treatment in prostate cancer
- Rocky start for Biogen’s Alzheimer’s drug Aduhelm
- David Hunt launches independent agency The Considered
- Live Webinar: Unlocking the Potential of Electronic Medical Records Using Artificial Intelligence
- Oxford PharmaGenesis wins Communiqué Medical Affairs Agency of the Year award at Communiqué 2021
- China backs use of Roche’s Actemra for coronavirus
- Future of MHRA uncertain amid Brexit-fuelled shake up
- Nicky Hutchens appointed as deputy managing director at Four Health
PMHub
Iguazu
Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...
Latest intelligence
- Understanding behaviour change: A Porterhouse Insights specialism
- ...
- Robust Review: COVID19 Assessment
- See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
- All change – how untangling human behaviour can encourage better health
- Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
